Cigna Investments’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-813
Closed -$202K 496
2026
Q1
$202K Buy
+813
New +$193K 0.03% 446
2025
Q4
Sell
-840
Closed -$235K 483
2025
Q3
$235K Buy
840
+39
+5% +$10.9K 0.03% 415
2025
Q2
$231K Sell
801
-44
-5% -$11.9K 0.04% 405
2025
Q1
$214K Buy
+845
New +$192K 0.04% 413
2024
Q1
Sell
-976
Closed -$201K 466
2023
Q4
$201K Buy
+976
New +$203K 0.04% 427
2023
Q3
Sell
-1,127
Closed -$254K 463
2023
Q2
$254K Hold
1,127
0.05% 381
2023
Q1
$238K Sell
1,127
-30
-3% -$6.18K 0.05% 391
2022
Q4
$238K Sell
1,157
-19
-2% -$3.64K 0.05% 386
2022
Q3
$204K Sell
1,176
-62
-5% -$11.5K 0.05% 413
2022
Q2
$206K Sell
1,238
-466
-27% -$85.5K 0.04% 434
2022
Q1
$379K Sell
1,704
-496
-23% -$108K 0.05% 378
2021
Q4
$558K Sell
2,200
-836
-28% -$193K 0.04% 343
2021
Q3
$623K Sell
3,036
-100
-3% -$21.9K 0.05% 363
2021
Q2
$715K Sell
3,136
-525
-14% -$114K 0.05% 329
2021
Q1
$727K Buy
3,661
+80
+2% +$15.7K 0.05% 341
2020
Q4
$775K Buy
3,581
+240
+7% +$49.1K 0.06% 294
2020
Q3
$684K Sell
3,341
-4,768
-59% -$985K 0.07% 271
2020
Q2
$1.68M Sell
8,109
-2,106
-21% -$437K 0.16% 129
2020
Q1
$1.84M Buy
10,215
+200
+2% +$39.3K 0.24% 88
2019
Q4
$2.08M Sell
10,015
-5
-0% -$939 0.22% 90
2019
Q3
$1.9M Buy
10,020
+7,007
+233% +$1.44M 0.2% 110
2019
Q2
$636K Hold
3,013
0.07% 330
2019
Q1
$547K Sell
3,013
-200
-6% -$34.3K 0.06% 367
2018
Q4
$476K Buy
3,213
+10
+0.3% +$1.5K 0.04% 346
2018
Q3
$457K Hold
3,203
0.04% 396
2018
Q2
$440K Sell
3,203
-27
-0.8% -$3.46K 0.03% 459
2018
Q1
$383K Sell
3,230
-47
-1% -$5.44K 0.03% 558
2017
Q4
$375K Sell
3,277
-300
-8% -$33.5K 0.02% 601
2017
Q3
$380K Sell
3,577
-2
-0.1% -$201 0.03% 578
2017
Q2
$333K Buy
+3,579
New +$323K 0.02% 600

Other funds holding VRSN

Cigna Investments's VRSN Position: Q2 2026 in Review

Cigna Investments sold out of VeriSign (VRSN) in Q2 2026, closing a stake of 813 shares — an estimated $202K sold.

Cigna Investments first reported a position in VRSN in Q2 2017 and held it in 30 quarters. The position peaked at $2.08M in Q4 2019. 126 funds tracked by Wall St. Rank hold VRSN as of Q2 2026.

  • Cigna Investments reported no remaining VeriSign position as of Q2 2026 after selling out during the quarter.
  • Cigna Investments sold 813 VeriSign shares in Q2 2026, an estimated $202K.
  • Cigna Investments first reported a position in VeriSign in Q2 2017 and held it in 30 quarters.
  • Cigna Investments's VeriSign position peaked at $2.08M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held VeriSign as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.